LC
Lindbrook Capital Portfolio holdings
AUM
$1.08B
1-Year Return
10.14%
This Quarter Return
-21.19%
1 Year Return
+10.14%
3 Year Return
+35.76%
5 Year Return
+141%
10 Year Return
–
AUM
$265M
AUM Growth
-$22.7M
(-7.9%)
Cap. Flow
+$41.2M
Cap. Flow
% of AUM
15.59%
Top 10 Holdings %
Top 10 Hldgs %
57.68%
Holding
1,963
New
414
Increased
438
Reduced
626
Closed
205
Top Buys
| 1 |
Golub Capital BDC
GBDC
|
+$9.54M |
| 2 |
EFR
Eaton Vance Senior Floating-Rate Fund
EFR
|
+$7.62M |
| 3 |
Nuveen Floating Rate Income Fund
JFR
|
+$7.48M |
| 4 |
NSL
NUVEEN SENIOR INCM FD
NSL
|
+$5.4M |
| 5 |
JRO
Nuveen Floating Rate Income Opportunty Fund
JRO
|
+$4.71M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.32M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$968K |
| 3 |
Vanguard Total International Stock ETF
VXUS
|
+$915K |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$529K |
| 5 |
Vanguard Value ETF
VTV
|
+$382K |
Sector Composition
| 1 | Financials | 9.13% |
| 2 | Technology | 8.55% |
| 3 | Healthcare | 3.83% |
| 4 | Consumer Staples | 2.53% |
| 5 | Real Estate | 2.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1151
H&R Block
HRB
$6.95B
| $3K | ﹤0.01% |
+185
| New | +$3K |
|
|
INN
1152
Summit Hotel Properties
INN
$625M
| $3K | ﹤0.01% |
+621
| New | +$3K |
|
1153
Gartner
IT
$18.6B
| $3K | ﹤0.01% |
31
-77
| -71% | -$7.45K |
|
1154
Vail Resorts
MTN
$5.36B
| $3K | ﹤0.01% |
17
-12
| -41% | -$2.12K |
|
1155
MYR Group
MYRG
$2.76B
| $3K | ﹤0.01% |
+106
| New | +$3K |
|
1156
PetMed Express
PETS
$57.8M
| $3K | ﹤0.01% |
97
| – | – |
|
1157
PTC
PTC
$24.6B
| $3K | ﹤0.01% |
56
-88
| -61% | -$4.71K |
|
|
QD
1158
Qudian
QD
$700M
| $3K | ﹤0.01% |
+1,936
| New | +$3K |
|
1159
Regency Centers
REG
$13.1B
| $3K | ﹤0.01% |
76
-36
| -32% | -$1.42K |
|
1160
Saic
SAIC
$4.94B
| $3K | ﹤0.01% |
37
+30
| +429% | +$2.43K |
|
1161
Alcoa
AA
$8.62B
| $3K | ﹤0.01% |
458
+20
| +5% | +$131 |
|
1162
American Airlines Group
AAL
$8.54B
| $3K | ﹤0.01% |
229
+58
| +34% | +$760 |
|
1163
ACI Worldwide
ACIW
$5.22B
| $3K | ﹤0.01% |
139
| – | – |
|
|
ADAP
1164
Adaptimmune Therapeutics
ADAP
$14M
| $3K | ﹤0.01% |
+938
| New | +$3K |
|
1165
Albemarle
ALB
$8.89B
| $3K | ﹤0.01% |
50
| – | – |
|
1166
Antero Midstream
AM
$8.93B
| $3K | ﹤0.01% |
+1,488
| New | +$3K |
|
1167
Algonquin Power & Utilities
AQN
$4.29B
| $3K | ﹤0.01% |
+200
| New | +$3K |
|
1168
AptarGroup
ATR
$8.98B
| $3K | ﹤0.01% |
28
-42
| -60% | -$4.5K |
|
|
AZUL
1169
DELISTED
Azul
AZUL
| $3K | ﹤0.01% |
+280
| New | +$3K |
|
1170
Booz Allen Hamilton
BAH
$12.9B
| $3K | ﹤0.01% |
48
| – | – |
|
1171
Bilibili
BILI
$10.5B
| $3K | ﹤0.01% |
+117
| New | +$3K |
|
1172
BioMarin Pharmaceuticals
BMRN
$10.5B
| $3K | ﹤0.01% |
36
+10
| +38% | +$833 |
|
1173
Bruker
BRKR
$4.76B
| $3K | ﹤0.01% |
76
+18
| +31% | +$711 |
|
1174
Brown & Brown
BRO
$31.1B
| $3K | ﹤0.01% |
96
| – | – |
|
1175
Burlington
BURL
$16.8B
| $3K | ﹤0.01% |
19
-17
| -47% | -$2.68K |
|